Member Info for Bella6532

Putting the data together and submitting it for peer review will happen this side of Christmas...I feel it in my bones. 22 December latest although they do have until 31 December but that being a Sunday the last trading day would be 29th December. Anything prior would be pure guesswork....

The big question is: What sort of Peer Review will they go for and how long will it take.

https://authorservices.taylorandfrancis.com/publishing-your-research/peer-review/types-peer-review/

No coincidence...

20th Sep 2023 7:01 am RNS Peel Hunt Appointed as Joint Broker

20th Sep 2023 7:00 am RNS Appointment Dr.Christina Coughlin as a consultant

19th Sep 2023 7:00 am RNS Successful Completion of Sixth Dose Escalation

Based on her past lives, she will be very much involved in getting the data presented properly and getting approvals etc.

Guys...chill

Might be absolutely nothing to do with AVA6000...could be huge contract win for one of our subs...or news relating to one of our existing deals...or new appointmdnt secured..or or or ...maybe no news at all just a positive trading day...uncapping bankers bonuses seems to have been taken well by the markets.

139...

138.01

And AZ and Pfizer have investd in Saama AI Tech which is supposed to help speed up Data results etc...

https://www.businesswire.com/news/home/20231017498809/en/Saama-Signs-New-Agreement-That-Will-Enable-Artificial-Intelligence-Driven-Drug-Development

Guys it's everywhere...AI is upon us whether we like it or not...

Anyone who has the scientific knowhow and wualifications to apply for and get a top scientific R&D job at Avacta...

Mmmm....thought so...lol!!!

Most of us might have the odd O Level in Chemistry but are now just Google warriers...

Going back to AVA6000...it's those cancer cells lurking unseen that are the problem. Hopefully AVA6000 is getting to those itsy bitsy ones too and perhaps case studies will show that further growths are not being seen. So many people go through misserable treatment and operations only to suffer from further growths which were simply too small to be seen at the time.

Do we know or will we get to know how FAP rich a cancer cell needs to be in order for AVA6000 to detect it?...that is the big question...

Lda and Bitl...haha...no nothing like that. Both held shares in another company and paths crossed on another BB.

Thanks O...

All's well thanks...

Afraid some on here don't realise we knew each other in a past life.

Chow for now and don't let the bed bugs bite...haha!!!

9 weeks max...

Wanting to included Case Studies would be huge since P1a was only supposed to be about safety and from what has already been RNS's they have clearly seen strong efficacy in at least one patient which would certainly generate a huge ripple in the scientific world if they were allowed to included this case study at this stage. It might also strengthen their case for moving the trial on and in effect leaving out P1b should peers concur.

Just gotta wait a tad longer...Q4 ends 31 December and the Christmas decorations are well and tuly in the stores so we're getting close... weeks max...

Https://www.colonialstock.com/otc-listings.htm

More likely Avactas broker has been doing the trading through the OTC msrket rather than Avacta arranging it. It's not like a stock exchange listing but more a facilitated trading platform.

Yuyus...may I suggest you simply do your own research. Most of what comes up on these BB's is easily found. Forget social media...I personally don't do it (never have) and have not had any side effects as a result. BB's can be useful but again are not always for the novice investor. Research should begin with reading the companies RNSs and if needs be print off and highlight using different colours for things like product, financials, R&D etc.

Then get to know the companies website inside and out....the mission statement..the teams etc. Then treat the company as a competitor and try to find out more about them and what they are up to out in their marketplace.

Your investment should be about what you want out of it not others and keep your expectations real for the time frame.

Chow....

You don't like people who tend to be somewhat over eager about their investment or overtly negative or posting one way or tuther on one or more social media sites then DON'T LOOK...switch off...stop logging in...stop reading what you consider to be ramping or deramping etc etc. As far as I know, NOBODY makes you log in, read posts on BBs or X or FB etc etc. Simply sign into your Google account and DYOR...

We live in a democracy and whether you like it or not many people feel they have the right to say and do what they like under the all encompassing 'free speech' banner.

You could go and live in a non- demographic country for a bit of peace and quiet I suppose...

Sigh...

Just to change the subject a little...and for those who might not know, Coris Bioconcepts is now part of the Avacta Group along with Launch Diagnotics.

'CORIS BIOCONCEPT SRL

Based in Belgium and established in 1996, Coris BioConcept is a middle-sized company (SME) specialized in developing, manufacturing and marketing rapid diagnostic kits for the detection of human respiratory, gastro-enteric and blood-borne pathogens (bacteria, viruses and parasites) and for the detection of antibiotic resistance markers (RESIST range). These tests are based on the lateral flow immunochromatography technology with colloidal gold particles or latex microspheres. These rapid tests are extensively used in microbiology laboratories worldwide.

Coris BioConcept was at the forefront to tackle COVID-19 by developing a rapid ICT assay for SARS-CoV-2 antigen detection. Recently, a serological single test has also been developed and validated for the detection and discrimination of antibodies against NP and RBD.

Coris BioConcept provides services for custom tests development and contract manufacturing. The company is present in more than 80 countries in Europe, Asia, South America, Africa and Oceania.

Coris BioConcept is continually involved in collaborative projects with Belgian and European Research Institutes, laboratories and companies for the development of breaking new solutions.

All Coris BioConcept’s products fulfil the CE marking requirements and the company is also ISO 13485 certified.'

https://www.medica-tradefair.com/vis/v1/en/exhprofiles/RYTW5rCtQxKUyE89034l1g?oid=80396&lang=2&_query=Coris

From yesterday and day before...haha

There's a 56k late trade not showing on LSE...

‘We need to see really strong science before we make these bets’

Bring on the data...

Looking at Point Biopharma Team...none seem to have worked for EL...lots of other big pharma but not EL. Not that it's a big deal but past employment might not be a good indicator when it comes to M&A's.